TITAN BIOTECH LTD. Share Price

BSE: 524717

₹ 419.00

-₹4.75 (-1.12%)

Last updated 24 Jul, 2026, 15:29 IST

TITAN BIOTECH LTD. Share Price Today

As of 25 Jul 2026, TITAN BIOTECH LTD. share price is ₹419.00. The stock opened at ₹414.00, compared to its previous close of ₹423.75. During today's trading session, TITAN BIOTECH LTD. share price moved in the range of ₹410.10 to ₹425.00, with an average price of ₹417.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹82.31 and a high of ₹555.65.

₹410.10

1.12% down today

₹425.00

1D LOW

1D HIGH

Latest Earning

Op Profit TrendUp by 56.63% YoY

Latest Earning

Net Profit TrendUp by 50.25% YoY

Latest Earning

Revenue TrendUp by 31.95% YoY

Stock Performance

OutperformingBeat Nifty by 1.27 % in last 1 month

Shareholding Pattern

DIIDII decreased stake by 76.47%

TITAN BIOTECH LTD. Returns Calculator

If you would've invested

₹

₹1,000₹1Cr

Historical Returns

1 Year

₹23,60,563+₹18,60,563 (+372.11%)

3 Year

₹39,56,563+₹34,56,563 (+691.31%)

5 Year

₹25,97,644+₹20,97,644 (+419.53%)

₹402.60₹444.90

Circuit Low

Circuit High

₹82.31₹555.65

52-Week Low

52-Week High

Circuit

₹402.60

₹444.90

52-week

₹82.31

₹555.65

Mkt Cap Cr

1,750.87

P/E

58.61

P/B

9.64

ROE

16.46%

D/E

0.03

ROCE

20.87%

Div. Yield

0.12%

EPS(TTM)

6.64

Turnover

1.16

EV/EBITDA

39.94

Net Margin

0.00%

Op. Margin

0.00%

ROA

12.83%

Quick Ratio

0.00

Curr. Ratio

3.87

Mkt Cap Cr

1,750.87

P/E

58.61

P/B

9.64

ROE

16.46%

D/E

0.03

ROCE

20.87%

Div. Yield

0.12%

EPS(TTM)

6.64

Turnover

1.16

EV/EBITDA

39.94

Net Margin

0.00%

Op. Margin

0.00%

ROA

12.83%

Quick Ratio

0.00

Curr. Ratio

3.87

Based on fundamentals, this stock's

Performance

Excellent

Titan Biotech outperforming all market indices

Valuation

Overvalued

Titan Biotech appears overvalued compared to its peers

Earnings

Neutral

Titan Biotech earnings growth is positive

Peer Comparison

Peer comparison — key ratios
Name	Mkt Cap Cr	P/E	P/B	ROE	D/E	ROCE	Book Value	Div. Yield	Turnover	EPS(TTM)
Sun Pharmaceutical Industries	4,65,711.00	36.73	5.05	14.85%	0.55	18.72%	18.85	0.91%	0.56	10.90
Divis Laboratories	1,93,860.00	61.36	9.40	16.19%	0.00	21.00%	9.43	0.50%	0.58	98.19
Torrent Pharmaceuticals	1,92,687.00	66.03	17.03	26.76%	1.05	18.30%	16.90	0.90%	0.49	64.75
Cipla	1,12,593.00	33.55	3.27	11.27%	0.00	14.95%	423.36	0.93%	0.44	43.52
Zydus Lifesciences	1,11,082.00	17.39	3.23	19.69%	0.35	20.30%	3.70	0.11%	0.39	35.38
Lupin	1,09,553.00	19.83	4.71	27.01%	0.03	27.44%	3.51	0.78%	0.61	129.18
Mankind Pharma	1,05,607.00	1.05	0.12	12.65%	0.42	12.97%	5.05	0.05%	0.54	49.37
Dr. Reddy's Laboratories	97,364.90	30.58	2.56	11.07%	0.18	12.54%	377.96	0.69%	0.41	38.68
Aurobindo Pharma	88,508.40	25.27	2.34	9.25%	0.19	11.76%	391.14	0.26%	0.48	41.58
Laurus Labs	84,727.30	60.26	10.10	18.21%	0.40	16.70%	97.21	0.12%	0.64	13.72

TITAN BIOTECH LTD. Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹156.45	₹164.07	₹144.00	₹123.55
Other Income	₹3.91	₹1.75	₹1.94	₹0.94
Total Revenue	₹160.36	₹165.82	₹145.94	₹124.49
Total Expenses	₹136.00	₹134.29	₹117.83	₹95.52
Profit Before Tax	₹24.37	₹31.53	₹28.12	₹28.97
Tax	₹6.10	₹7.87	₹7.09	₹7.28
Profit After Tax	₹18.27	₹23.66	₹21.02	₹21.68
EPS - Basic	₹26.06	₹30.07	₹30.06	₹26.24
EPS - Diluted	₹26.06	₹30.07	₹30.06	₹26.24

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹24.37	₹31.53	₹28.12	₹28.97
Income before WC changes	₹29.66	₹36.29	₹31.64	₹32.49
Change in Assets	-₹6.34	-₹5.77	-₹6.27	-₹5.82
Change in Liabilities	₹2.80	-₹1.51	₹3.31	₹2.49
Change in WC	-₹3.55	-₹7.28	-₹2.96	-₹3.33
Cash flow from Operations	₹20.12	₹21.15	₹21.18	₹22.04
Cash flow from Investing	-₹9.87	-₹20.30	-₹20.73	-₹16.44
Cash flow from Financing	-₹7.96	-₹2.87	-₹2.40	-₹4.10
Total Cash Flow	₹2.29	-₹2.02	-₹1.95	₹1.51
Cash (Start of the year)	₹2.84	₹4.86	₹6.81	₹5.31
Cash (End of the year)	₹5.13	₹2.84	₹4.86	₹6.81

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹95.67	₹84.41	₹66.21	₹44.34
Current Assets	₹79.04	₹72.62	₹68.31	₹63.76
Total Assets	₹174.71	₹157.03	₹134.52	₹108.09
Current Liabilities	₹17.74	₹19.57	₹20.35	₹16.95
Net Current Asset	₹61.30	₹53.05	₹47.96	₹46.81
Non-Current Liabilities	₹3.57	₹4.00	₹4.25	₹4.90
Equity Capital	₹153.40	₹133.45	₹109.91	₹86.24
Total Equity & Liabilities	₹174.71	₹157.03	₹134.52	₹108.09

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Revenue	₹156.45	₹164.07	₹144.00	₹123.55
Other Income	₹3.91	₹1.75	₹1.94	₹0.94
Total Revenue	₹160.36	₹165.82	₹145.94	₹124.49
Total Expenses	₹136.00	₹134.29	₹117.83	₹95.52
Profit Before Tax	₹24.37	₹31.53	₹28.12	₹28.97
Tax	₹6.10	₹7.87	₹7.09	₹7.28
Profit After Tax	₹18.27	₹23.66	₹21.02	₹21.68
EPS - Basic	₹22.11	₹28.64	₹25.44	₹26.24
EPS - Diluted	₹22.11	₹28.64	₹25.44	₹26.24

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Profit before tax	₹24.37	₹31.53	₹28.12	₹28.97
Income before WC changes	₹29.66	₹36.29	₹31.64	₹32.49
Change in Assets	-₹6.34	-₹5.77	-₹6.27	-₹5.82
Change in Liabilities	₹2.80	-₹1.51	₹3.31	₹2.49
Change in WC	-₹3.55	-₹7.28	-₹2.96	-₹3.33
Cash flow from Operations	₹20.12	₹21.15	₹21.18	₹22.04
Cash flow from Investing	-₹9.87	-₹20.30	-₹20.73	-₹16.44
Cash flow from Financing	-₹7.96	-₹2.87	-₹2.40	-₹4.10
Total Cash Flow	₹2.29	-₹2.02	-₹1.95	₹1.51
Cash (Start of the year)	₹2.84	₹4.86	₹6.81	₹5.31
Cash (End of the year)	₹5.13	₹2.84	₹4.86	₹6.81

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
Particulars	Mar 2025	Mar 2024	Mar 2023	Mar 2022
Non-Current Assets	₹87.40	₹79.40	₹62.39	₹44.34
Current Assets	₹79.04	₹72.17	₹68.31	₹63.76
Total Assets	₹166.44	₹151.57	₹130.70	₹108.09
Current Liabilities	₹17.74	₹19.13	₹20.35	₹16.95
Net Current Asset	₹61.30	₹53.05	₹47.96	₹46.81
Non-Current Liabilities	₹3.57	₹4.00	₹4.25	₹4.90
Equity Capital	₹145.13	₹128.44	₹106.09	₹86.24
Total Equity & Liabilities	₹166.44	₹151.57	₹130.70	₹108.09

* All values are in INR Crore

Qty

Bid

Ask

Qty

Bid Total: 0

Ask Total: 0

Buy orders: 0%

Sell orders: 0%

30 levels of bid & ask depth

Supply & Demand Zones

Bearish

Neutral

Bullish

Slightly Bearish

by SEBI experts available for this stock

Earn more using advisory

by SEBI experts

Expert Pick

EXPPICK

Stop-loss

Entry price

Target

Indicator

Value

Verdict

RSI (14)

51.84

Neutral

ATR (14)

20.66

Neutral

STOCH(9,6)

72.03

Neutral

STOCH RSI (14)

69.97

Neutral

ADX(9)

21.44

Bearish

UO(9)

72.98

Bearish

ROC(12)

5.44

Bullish

WillR(14)

-27.79

Neutral

Period

Simple value

Exponential vaue

425.41

422.47

10D

414.31

416.83

20D

402.67

413.94

50D

425.78

417.25

100D

418

394.57

About TITAN BIOTECH LTD.

ISIN

INE150C01029

Sector Market Cap

₹ 1,750.87 Cr

Titan Biotech Limited is an India-based manufacturer and exporter of biological products. The Company is a manufacturer of clinically approved collagen (fish, bovine, and chicken), skin care ingredients, bone and joint care ingredients, proteins, animal nutrition ingredients and many more. It can provide any microbiology product that its customers need from powder culture media to prepared media. Its product categories include food ingredients, collagen and proteins, pharmaceuticals and nutraceuticals, animal nutrition, probiotics and fermentation ingredients, agriculture products, and culture media. The Company's food ingredients include flavoring and food preservative and improvers. Its collagen and proteins include wheat protein hydrolysate and collagen peptides. Its nutraceuticals include milk protein and bovine cartilage extract. Its animal nutrition includes binding agent, chelates minerals and yeast. Its agriculture products include bio fungicide, insecticides and acaricides.

TITAN BIOTECH LTD. Financial Highlights

Revenue: TITAN BIOTECH LTD. reported revenue of ₹211.60 crore in FY26 vs ₹160.36 crore in FY25. It showed an increase of 31.95% on a yearly basis.
Operating Profit: TITAN BIOTECH LTD. reported an operating profit of ₹38.17 crore in FY26 vs ₹24.37 crore in FY25. It showed an increase of 56.63% on a year-on-year basis.
Net Profit: TITAN BIOTECH LTD. reported a net profit of ₹27.45 crore in FY26 vs ₹18.27 crore in FY25. It showed an increase of 50.25% on a yearly basis.

TITAN BIOTECH LTD. Quarterly Result Highlights

TITAN BIOTECH LTD. reported revenue of ₹50.94 crore in Mar 2026, compared with ₹57.77 crore in Dec 2025, representing a decrease of 11.82% on a quarter-on-quarter (QoQ) basis.
TITAN BIOTECH LTD. reported an operating profit of ₹10.28 crore in Mar 2026, compared with ₹10.56 crore in Dec 2025, representing a decrease of 2.65% on a quarter-on-quarter (QoQ) basis.
TITAN BIOTECH LTD. reported a profit of ₹6.56 crore in Mar 2026, compared with ₹7.87 crore in Dec 2025, reflecting a decrease of 16.65% on a QoQ basis.
The earnings per share (EPS) of TITAN BIOTECH LTD. stood at ₹26.06 during Mar 2026.